Filters
reset all| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
QDx Pathology Services, Inc. United States | 4 | 3 |
|
Clariti Diagnostics Laboratories LLC United States | 4 | 3 |
|
Hereditary Cancer Panel Comprehensive Molecular Genetics Laboratory London Health Sciences Centre Canada | 39 | 30 |
|
Genesys Diagnostics Genesys Diagnostics, Inc. United States | 58 | 43 |
|
Hereditary Cancer Screening - Common Hereditary Cancer Panel (41 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 47 | 41 |
|
Hereditary Cancer Screening - Full Hereditary Cancer Panel (99 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 109 | 99 |
|
GeneID Lab - Advanced Molecular Diagnostics United States | 60 | 34 |
|
Common Hereditary Cancer Screening Panel PreventionGenetics, part of Exact Sciences United States | 94 | 55 |
|
Centogene AG - the Rare Disease Company Germany | 114 | 68 |
|
Centogene AG - the Rare Disease Company Germany | 156 | 107 |
|
Centogene AG - the Rare Disease Company Germany | 218 | 135 |
|
Invitae Common Hereditary Cancers + RNA Panel Invitae United States | 114 | 47 |
|
Ambry Genetics United States | 79 | 37 |
|
Variant Resolution Test for CancerNext® 37 (+RNAinsight®) Ambry Genetics United States | 79 | 18 |
|
PathGroup United States | 73 | 505 |
|
Variant Resolution Test for Penn Cancer Grant Panel (+RNAinsight®) Ambry Genetics United States | 79 | 18 |
|
Ambry Genetics United States | 79 | 80 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Melanoma, cutaneous malignant, 3, 609048, Autosomal dominant; CMM3 (Familial melanoma) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
IntelligeneCG LLC United States | 13 | 9 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.